Lucas P
Michigan Psychedelic Center, University of Michigan, Ann Arbor, MI, USA.
PreprintPsychedelics
Contexts, Risks, and Affordances among Autistic Adults Using Psychedelics for Therapeutic Purposes: A Naturalistic, Mixed-Methods Study
ArticleKetamine
Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey.
ArticlePsilocybin
Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.
PreprintPsychedelics
Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample
ArticlePsychedelics
Psychedelics for the management of symptoms of traumatic brain injury: Findings from the global psychedelic survey.
ArticlePsilocybin
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.
ArticlePsilocybin
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.
ArticlePsychedelics
Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples.
ArticlePsychedelics
Preferences and Attitudes Toward Music in Nonclinical Uses of Psychedelics.
ArticlePsilocybin
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.
ArticleAyahuasca
Co-use of psychedelics with other substances: Findings from the global psychedelic survey.
ArticlePsilocybin
The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.
ArticlePsilocybin
Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.
ArticlePsilocybin